BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 17317369)

  • 1. Impact of the metabolic syndrome on the clinical outcomes of non-clinically diagnosed diabetic patients with acute coronary syndrome.
    Feinberg MS; Schwartz R; Tanne D; Fisman EZ; Hod H; Zahger D; Schwammethal E; Eldar M; Behar S; Tenenbaum A
    Am J Cardiol; 2007 Mar; 99(5):667-72. PubMed ID: 17317369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic syndrome does not increase angiographic restenosis rates after drug-eluting stent implantation.
    Canibus P; Faloia E; Piva T; Muçai A; Serenelli M; Perna GP; Boscaro M; Piva R
    Metabolism; 2008 May; 57(5):593-7. PubMed ID: 18442619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of the metabolic syndrome and hyperuricemia on outcome in patients with coronary artery disease (from the Bezafibrate Infarction Prevention Study).
    Brodov Y; Behar S; Boyko V; Chouraqui P
    Am J Cardiol; 2010 Dec; 106(12):1717-20. PubMed ID: 21126615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. All-cause mortality risk predictors in a preventive cardiology clinic cohort-examining diabetes and individual metabolic syndrome criteria: a PRECIS database study.
    Doshi KB; Kashyap SR; Brennan DM; Hoar BM; Cho L; Hoogwerf BJ
    Diabetes Obes Metab; 2009 Feb; 11(2):102-8. PubMed ID: 18494803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence and impact of metabolic syndrome on hospital outcomes in acute myocardial infarction.
    Zeller M; Steg PG; Ravisy J; Laurent Y; Janin-Manificat L; L'Huillier I; Beer JC; Oudot A; Rioufol G; Makki H; Farnier M; Rochette L; Vergès B; Cottin Y;
    Arch Intern Med; 2005 May; 165(10):1192-8. PubMed ID: 15911735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of admission heart failure in patients with non-ST-elevation acute coronary syndromes (from the Canadian Acute Coronary Syndrome Registries).
    Segev A; Strauss BH; Tan M; Mendelsohn AA; Lai K; Ashton T; Fitchett D; Grima E; Langer A; Goodman SG;
    Am J Cardiol; 2006 Aug; 98(4):470-3. PubMed ID: 16893699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of metabolic syndrome in heart transplant patients: role of previous cardiopathy and years since the procedure--the TRACA study.
    Cordero Fort A; Gavira JJ; Alegría-Barrero E; Castaño S; Martín A; Ubilla M; Mastrobuoni S; Alegría Ezquerra E; Herreros J; Rábago G
    J Heart Lung Transplant; 2006 Oct; 25(10):1192-8. PubMed ID: 17045931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of metabolic syndrome after acute coronary syndrome and its prognostic significance.
    Boulon C; Lafitte M; Richeboeuf V; Paviot B; Pradeau V; Coste P; Bonnet J; Couffinhal T
    Am J Cardiol; 2006 Dec; 98(11):1429-34. PubMed ID: 17126644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary coronary intervention in diabetic octogenarians with acute ST elevation myocardial infarction.
    Sosnowski C; Janeczko-Sosnowska E; Woźniak J; Jasiński B; Dabrowski R; Sumiński A; Wiernikowski A; Ostrzycki A; Szwed H; Ruzyłło W
    Kardiol Pol; 2007 Oct; 65(10):1181-6; discussion 1187-9. PubMed ID: 17979046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bezafibrate for the secondary prevention of myocardial infarction in patients with metabolic syndrome.
    Tenenbaum A; Motro M; Fisman EZ; Tanne D; Boyko V; Behar S
    Arch Intern Med; 2005 May; 165(10):1154-60. PubMed ID: 15911729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of inflammatory markers on cardiovascular mortality in patients with metabolic syndrome.
    Espinola-Klein C; Rupprecht HJ; Bickel C; Lackner K; Genth-Zotz S; Post F; Munzel T; Blankenberg S;
    Eur J Cardiovasc Prev Rehabil; 2008 Jun; 15(3):278-84. PubMed ID: 18525381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of metabolic syndrome on future cardiovascular events in patients with first acute myocardial infarction.
    Selcuk H; Temizhan A; Selcuk MT; Sen T; Maden O; Tekeli S; Sasmaz A
    Coron Artery Dis; 2009 Sep; 20(6):370-5. PubMed ID: 19609207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of metabolic syndrome's components on the development of cardiovascular disease in a Jordanian cohort with metabolic syndrome.
    Haddad FH; Mahafza SM
    Saudi Med J; 2008 Sep; 29(9):1299-305. PubMed ID: 18813416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A clinically practicable diagnostic score for metabolic syndrome improves its predictivity of diabetes mellitus: the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico (GISSI)-Prevenzione scoring.
    Macchia A; Levantesi G; Borrelli G; Franzosi MG; Maggioni AP; Marfisi R; Scarano M; Tavazzi L; Tognoni G; Valagussa F; Marchioli R; ; ;
    Am Heart J; 2006 Mar; 151(3):754.e7-754.e17. PubMed ID: 16504647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of metabolic syndrome on coronary patency after thrombolytic therapy for acute myocardial infarction.
    Yasar AS; Bilen E; Bilge M; Arslantas U; Karakas F
    Coron Artery Dis; 2009 Sep; 20(6):387-91. PubMed ID: 19696662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IDF and ATP-III definitions of metabolic syndrome in the prediction of all-cause mortality in type 2 diabetic patients.
    Monami M; Marchionni N; Masotti G; Mannucci E
    Diabetes Obes Metab; 2007 May; 9(3):350-3. PubMed ID: 17391162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of admission hyperglycemia and diabetes mellitus on short- and long-term mortality after acute myocardial infarction in the coronary intervention era.
    Ishihara M; Kagawa E; Inoue I; Kawagoe T; Shimatani Y; Kurisu S; Nakama Y; Maruhashi T; Ookawa K; Dai K; Aokage Y
    Am J Cardiol; 2007 Jun; 99(12):1674-9. PubMed ID: 17560874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic syndrome increases operative mortality in patients undergoing coronary artery bypass grafting surgery.
    Echahidi N; Pibarot P; Després JP; Daigle JM; Mohty D; Voisine P; Baillot R; Mathieu P
    J Am Coll Cardiol; 2007 Aug; 50(9):843-51. PubMed ID: 17719470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic syndrome is associated with severe coronary artery disease and poor cardiac outcome in end-stage renal disease patients with acute coronary syndrome.
    Chen HH; Wu CJ; Chen YC; Tsai CS; Lin FJ; Yeh HI
    Coron Artery Dis; 2006 Nov; 17(7):593-6. PubMed ID: 17047442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of admission glucose level and presence of diabetes mellitus on mortality in patients with non-ST-segment elevation acute coronary syndrome treated conservatively.
    Dziewierz A; Giszterowicz D; Siudak Z; Rakowski T; Mielecki W; Suska M; Dubiel JS; Dudek D
    Am J Cardiol; 2009 Apr; 103(7):954-8. PubMed ID: 19327422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.